IgniteData and Memorial Sloan Kettering Cancer Center Announce Collaboration
IgniteData has announced a new collaboration with Memorial Sloan Kettering Cancer Center (MSK). Joining the MSK Innovation Hub, IgniteData will provide data transfer integration between the EHR at MSK and the electronic systems of two major clinical trial sponsors, with the expectation of expanding this project to include additional sponsors and trials. The collaboration is aiming to improve the process of data collection for cancer research by reducing the requirement for time-consuming data duplication and source data verification (SDV).
IgniteData’s system-agnostic electronic data transfer technology, Archer, eliminates the need for researchers to manually transcribe data such as vital signs and labs. Archer’s Smart Mapping Engine matches site and sponsor ontologies and normalises complex healthcare data. The solution enables research staff to transfer existing regulatory-grade data from the EHR to the sponsor’s study database.
The MSK Innovation Hub brings together health technology innovators and MSK’s community of researchers, clinicians, and digital health professionals through a program designed to advance the prevention, treatment, and cure of cancer. The MSK Innovation Hub is targeted at accelerating development of innovative products and businesses.
Reference
IgniteData and Leading New York City Cancer Center Collaborate to Solve the Clinical Trial Data Transfer Challenge. (2023, June). IgniteData.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
